Lifeward (LFWD) Capital Expenditures (QoQ) (2015 - 2023)
Lifeward (LFWD) Capital Expenditures (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3,850.00% |
| Sep 30, 2022 | -53.33% |
| Jun 30, 2022 | 400.00% |
| Mar 31, 2022 | -84.21% |
| Dec 31, 2021 | 11.76% |
| Sep 30, 2021 | 750.00% |
| Jun 30, 2021 | -77.78% |
| Sep 30, 2020 | 866.67% |
| Jun 30, 2020 | -33.33% |
| Mar 31, 2020 | -35.71% |
| Dec 31, 2018 | 66.67% |
| Dec 31, 2017 | 166.67% |
| Sep 30, 2017 | -125.00% |
| Jun 30, 2017 | 20.00% |
| Mar 31, 2017 | -77.27% |
| Dec 31, 2016 | 238.46% |
| Sep 30, 2016 | -95.11% |
| Jun 30, 2016 | 106.20% |
| Mar 31, 2016 | -15.13% |
| Dec 31, 2015 | 87.65% |